← All insiders

PCVX

Vaxcyte, Inc.

24 transactions on file, per SEC Form 4 filings.

See PCVX superinvestor activity →

Wassil Jim

EVP, Chief Scientific Ofc, COO · 2026-09-09

Sold

$79K

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · 2026-09-08

Tax withholding

$1.0M

GUGGENHIME ANDREW

PRESIDENT AND CFO · 2026-09-08

Tax withholding

$432K

Dhaliwal Harpreet S.

Chief Technical Ops Officer · 2026-09-08

Tax withholding

$462K

Cowan Elvia

SVP, Finance & CAO · 2026-09-08

Tax withholding

$80K

Wassil Jim

EVP, Chief Scientific Ofc, COO · 2026-09-08

Tax withholding

$330K

Wassil Jim

EVP, Chief Scientific Ofc, COO · 2026-09-04

Sold

$84K

Jodar Luis

Chief Medical Officer · 2026-09-04

Award

52,632 sh

Jodar Luis

Chief Medical Officer · 2026-09-04

Award

$5.4M

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-02

Tax withholding

$88K

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · 2026-09-02

Tax withholding

$211K

GUGGENHIME ANDREW

PRESIDENT AND CFO · 2026-09-02

Tax withholding

$88K

Dhaliwal Harpreet S.

Chief Technical Ops Officer · 2026-09-02

Tax withholding

$41K

Cowan Elvia

SVP, Finance & CAO · 2026-09-02

Tax withholding

$20K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-01

Option exercise

$12K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-01

Sold

$94K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-01

Sold

$44K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-01

Sold

$56K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-09-01

Sold

$19K

Wassil Jim

CHIEF OPERATING OFFICER · 2026-08-31

Tax withholding

$77K

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · 2026-08-31

Tax withholding

$174K

GUGGENHIME ANDREW

PRESIDENT AND CFO · 2026-08-31

Tax withholding

$77K

Dhaliwal Harpreet S.

Chief Technical Ops Officer · 2026-08-31

Tax withholding

$22K

Cowan Elvia

SVP, Finance & CAO · 2026-08-31

Tax withholding

$15K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is PCVX actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.

Analyze PCVX